| Product Name |
CAS Registry Number |
Molecular Formula |
| Byakangelicin | 482-25-7 | C17H18O7 |
| Byakangelicol | 26091-79-2 | C17H16O6 |
| (+/-)-Byakangelicol | 61046-59-1 | C17H16O6 |
| BYL-719 | 1217486-61-7 | C19H22F3N5O2S |
| Byssotoxin A | 57560-20-0 | C25H26N2O3 |
| Byzantionoside B | 189109-45-3 | C19H32O7 |
| C11-C15-Secondaryalcohols ethoxylated butoxylated | 1022990-65-3 | |
| C11-14-iso-Alcohols,C13-rich, ethoxylated | 78330-21-9 | C13H27(OCH2CH2)nOH |
| C12-18-Alkyl[(ethylphenyl)methyl]dimethylammonium chlorides | 68956-79-6 | |
| C12-15 Alkyl lactate | 93925-36-1 | |
| C12-C14 tert-Alkylamines ethoxylated | 73138-27-9 | |
| C13-C14 Isoparaffin | 64365-06-6 | |
| C13-C16 Isoparaffin | 68551-20-2 | |
| C14-C18 trialkyl amine | 67701-00-2 | |
| C14-C22 and C16-C22 unsaturated trialkyl glycerides | 68424-59-9 | |
| C18-fatty acids dimers polymers with adipic acid and neopentyl glycol | 276869-34-2 | |
| C18-unsaturated fatty acids dimers polymers with diethylene glycol | 68552-01-2 | |
| C20-GLU-AEEA-AEEA-OSU | 1188328-38-2 | C41H70N4O15 |
| C20-Otbu-glu-otbu | 1119061-70-9 | C33H61NO7 |
| C20-OTBU-GLU(OTBU)-AEEA-AEEA-OSU | 1118767-17-1 | C49H86N4O15 |
| C36 Dimer acid | 61788-89-4 | C36H64O4 |
| C9 Branched alkyl phenol ethoxylate phosphates | 68412-53-3 | |
| CA-074 | 134448-10-5 | C18H29N3O6 |
| Cabazitaxel | 183133-96-2 | C45H57NO14 |
| Cabazitaxel intermediate | 1354900-65-4 | C51H59NO15 |
| Cabergoline | 81409-90-7 | C26H37N5O2 |
| Cabergoline diphosphate | 85329-89-1 | C26H37N5O2.2(H3PO4) |
| Cabotegravir Impurity 10 | 2757656-11-2 | C12H12N2O6 |
| Cabotegravir Impurity 19 | 1284487-51-9 | C14H11F4N |
| Cabotegravir Impurity 2 | 1646862-08-9 | C19H17F2N3O5 |
| Cabotegravir Impurity 9 | 1335210-31-5 | C11H11NO7 |
| Cabotegravir Intermediate | 1335210-24-6 | C13H14N2O6 |
| Cabotegravir sodium | 1051375-13-3 | C19H16F2N3O5.Na |
| Caboxine A | 53851-13-1 | C22H26N2O5 |
| Cabozantinib | 849217-68-1 | C28H24FN3O5 |
| cabozantinibimpurity16 | 2439164-91-5 | C39H34N4O8 |
| Cabozantinib Impurity 12 | 35654-35-4 | C17H16N2O3 |
| Cabozantinib Impurity 15 | 213699-53-7 | C15H17NO6 |
| Cabozantinib Impurity 25 | 1628530-47-1 | C27H22FN3O5 |
| Cabozantinib Impurity 5 | 1431468-36-8 | C17H14F2N2O2 |
| Cabozantinib N-oxide | 1621681-63-7 | C28H24FN3O6 |
| Cabraleadiol | 67253-01-4 | C30H52O3 |
| Cabraleadiol 3-acetate | 35833-62-6 | C32H54O4 |
| Cabraleahydroxylactone | 35833-69-3 | C27H44O3 |
| Cabraleahydroxylactone acetate | 35833-70-6 | C29H46O4 |
| Cabralealactone | 19865-87-3 | C27H42O3 |
| Cabraleone | 35761-54-7 | C30H50O3 |
| Cacodylic acid | 75-60-5 | C2H7AsO2 |
| Cacotheline | 561-20-6 | C21H21N3O7 |
| N-Boc-cadaverine | 51644-96-3 | C10H22N2O2 |